GENE ONLINE|News &
Opinion
Blog

Reed Slater

WRITTEN BY Reed Slater

Saudi Arabia to Invest $3.4 Billion in Latest Push to Develop Biotechnology Presence
2022-06-29
Amgen Out-Licenses Two Therapies to Fosun Pharma to Expand Presence in China
2022-06-28
Roe Reversal May Cause Downstream Issues in Repurposing Mifepristone
2022-06-27
F-star Therapeutics Signs On to invoX Pharma for $161 Million to Stay Afloat
2022-06-24
America’s Ongoing Battle For Lower Insulin Prices
2022-06-23
Human Longevity Plans to Merge With Blank Check Company to Go Public
2022-06-22
Valneva Receives Funding From Pfizer to Develop World’s Only Lyme Disease Vaccine
2022-06-21
Three Companies Received Orphan Drug Designations in One Day To Treat Rare Cancers
2022-06-20
Akero Receives Up To $125 Million To Continue Liver Disease Treatment Development
2022-06-17
Bristol Myers Squibb Requests $1.2 Billion Patent Revival From Supreme Court
2022-06-17
MorphoSys Thins Pipeline For Potential $1 Billion Deal While Progressing Oncology Ambitions
2022-06-16
Elektrofi Secures $40 Million in Series B Funding For Drug Delivery Development
2022-06-15
Ushering In A New Generation Of AI-Focused Investments Opportunities
2022-06-14
Eli Lilly Nabs FDA Approval For First-Ever Systemic Treatment Targeting Alopecia Areata
2022-06-14
Series A Funding Successfully Wraps Up for Two Up-and-Coming Biotechs
2022-06-10
1 10 11 12 13 14 15
Scroll to Top